Ignite Creation Date:
2025-12-24 @ 1:28 PM
Ignite Modification Date:
2026-06-05 @ 1:20 PM
Study NCT ID:
NCT01440595
Status:
TERMINATED
Last Update Posted:
2024-05-22
First Post:
2011-09-22
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Grazoprevir (MK-5172) With Peg-Interferon and Ribavirin in Participants With Chronic Genotype 2 or 3 Hepatitis C (MK-5172-012)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Hepatitis C, Chronic | View |
Keywords: